ArticleEClinicalMedicine2024

Camrelizumab, chemotherapy and apatinib in the neoadjuvant treatment of resectable oesophageal squamous cell carcinoma: a single-arm phase 2 trial.

Zixiang Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.